Skip to main content

Table 10 SUCRA ranking of FVC (% predicted) absolute change from baseline

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Treatment

SUCRA

PrBest

MeanRank

Ambrisentan

84.9

61.5

2.1

Warfarin

79.3

26.8

2.5

Placebo

70.3

2.9

3.1

Sildenafil

62.5

5.9

3.6

Nintedanib

36.3

1.6

5.5

Pirfenidone

30.8

0.5

5.8

PRM151

19.3

0.4

6.7

Pamrevlumab

16.6

0.3

6.8

  1. Higher values of SUCRA indicate higher values of decline in FVC (% predicted) absolute change from baseline
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us